Staurosporine exhibits nanomolar IC50 values against a wide range of protein kinases. The structure of a CDK2 strauroporine complex explains the tight binding of this inhibitor, and suggests features to be exploited in the design of specific inhibitors of CDKs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting CDK1 in cancer: mechanisms and implications
npj Precision Oncology Open Access 13 June 2023
-
PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling
Nature Communications Open Access 27 May 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tamaoki, T. et al. Biochem. Biophys. Res. Commun. 135, 397–402 (1986).
Meggio, F. et al. Eur. J. Biochem. 234, 317–322 (1995).
Omura, S., Sasaki, Y., Iwai, Y. & Takeshima, H. J. Antibiot. 48, 535–548 (1995).
Jacobson, M.D., Weil, M. & Raff, M.C. J. Cell Biol. 133, 1041–1051 (1996).
Schnier, J.B., Nishi, K., Goodrich, D.W. & Bradbury, M.E. Proc. Natl. Acad. Sci. USA 93, 5941–5946 (1996).
Morgan, D.O. Nature 374, 131–134. (1995).
Knighton, D.R. et al. Science 253, 407–414 (1991).
Xu, R.-M., Carmel, G., Kuret, J. & Cheng, X. Proc. Natl. Acad. Sci. USA 93, 6308–6313 (1996).
Tong, L. et al. Nature Struct. Biol. 4, 311–316. (1997).
Funato, N., Takayanagi, H., Konda, Y., Toda, Y. & Harigaya, Y. Tetrahedron Letts 35, 1251–1254 (1994).
Russo, A.A., Jeffrey, P.D. & Pavletich, N.P. Nature Struct. Biol. 3, 696–700 (1996).
Schulze-Gahmen, U. et al. Prots: Struct Funct. Genet 22, 378–391 (1995).
DeBondt, H.L. et al. Nature 363, 595–602 (1993).
De Azevedo, W.F. et al. Proc. Natl. Acad. Sci. USA 93, 2735–2740 (1996).
Furct, P. et al. J. Comput. Aided Drug Design 9, 465–472 (1995).
De Azevedo, W.F. et al. Eur. J. Biochem. 243, 518–526 (1997).
Cox, S., Radzio-Andzelm, E. & Taylor, S.S. Curr. Opin. Struct. Biol. 4, 893–901 (1994).
Hanks, S.K. & Hunter, T. FASEB J. 9, 576–596 (1995).
Toullec, D. et al. J. Biol. Chem 266, 15771–15781 (1991).
Bit, R.A. et al. J. Med. Chem 36, 21–29 (1993).
Buchdunger, E. et al. Proc. Natl. Acad. Sci. USA 91, 2334–2338 (1994).
Trinks, U. et al. J. Med. Chem. 37, 1015–1027 (1994).
Meijer, L. Trends Cell Biol. 6, 393–397 (1996).
Gadbois, D., Hamaguchi, J.R., Swank, R.A. & Bradbury, E.M. Biochem. Biophys. Res. Commun. 184, 80–85 (1992).
Meijer, L. Chemical inhibitors of cyclin-dependent kinases. in Progress in Cell Cylce Research Vol. 1 (ed. Meijer, L, Guidet, S., and Tung, H.YL.) 1–13 (Plenum Press, New York, 1995).
Kinnel, R.B. & Scheuer, P.J. J. Org. Chem 57, 6327–6329 (1992).
Osada, K., Takahashi, H., Tsunoda, K., Kusakabe, H. & Isono, K. J. Antibiotics 43, 163–167 (1990).
Kase, H. et al. Biochem. Biophys. Res. Commun. 142, 436–440 (1987).
Sherr, C.J. Science 274, 1672–1677 (1996).
Rosenblatt, J., De, B.H., Jancarik, J., Morgan, D.O. & Kim, S.H. J Mol Biol 230, 1317–1319 (1993).
Otwinowski, Z. Oscillation data reduction program, in Data collection and processing (eds Sawyer, L., Isaacs, N. & Bailey, S.) 56–62 (SERC Daresbury Laboratory, Warrington, U.K., 1993).
Navaza, J. Acta. Crystallogr. A50, 157–163 (1994).
Brünger, A.T. X-PLOR, A system for X-ray crystallography and NMR. 3.1 edn (Yale University Press, New Haven., 1992).
Jones, T.A., Zou, J.Y., Cowan, S.W., Kjeldgaard, M. Acta Crystallographica A 47, 110–119 (1991).
Murshudov, G.N., Dodson, E.J. & Vagin, A.A. Application of maximum likelihood methods for macromolecular refinement, in Macromolecular refinement (eds Dodson, E., Moore, M., Ralph, A. & Bailey, S.) (CCLRC, Chester, UK, 1996).
Lamzin, V.S. & Wilson, K.S. Acta Crystallogr. D49, 129–147 (1993).
Connolly, M.L. J. Applied Crystallogr. 16, 548–558 (1983).
Wallace, A.C., Laskowski, R.A. & Thornton, J.M. Prot Engng 8, 127–134 (1995).
Kabsch, W. & Sander, C. Biopolymers 22, 2577–2637 (1983).
Russell, R.B. & Barton, G.J. Proteins: Struct, Funct Genets. 14, 309–323 (1992).
Barton, G.J. Methods Enz. 183, 403–427 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lawrie, A., Noble, M., Tunnah, P. et al. Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nat Struct Mol Biol 4, 796–801 (1997). https://doi.org/10.1038/nsb1097-796
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsb1097-796
This article is cited by
-
Targeting CDK1 in cancer: mechanisms and implications
npj Precision Oncology (2023)
-
Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study
Molecular Diversity (2023)
-
PI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling
Nature Communications (2022)
-
Indolo[2,3-a]carbazoles: diversity, biological properties, application in antitumor therapy
Chemistry of Heterocyclic Compounds (2020)
-
Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3)
Journal of Molecular Modeling (2013)